Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Acute GastritisChronic Gastritis
Interventions
DRUG

Eupasidin-s Tab

three times per day, 1 tab for each time, PO, during 2weeks

DRUG

Stillen Tab.

three times per day, 1 tab for each time, PO, during 2weeks

Trial Locations (10)

614-735

Inje University Busanpaik hospital, Busan

561-712

Chonbuk National University Hospital, Jeonju

501-757

Chonnam National University Hospital, Guangju

220-701

Wonju Severance Christian Hospital, Wŏnju

301-721

Chungnam National University Hospital, Daejeon

570-711

Wonkwang University School of Medicine & Hospital, Iksan

705-703

Yeungnam University Medical Center, Daegu

602-702

Kosin University Gospel Hospital, Busan

602-812

Dong-A University Hospital, Busan

133-792

Hanyang University Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY